Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
add, alternative, Bioprojet, cancer, cell, Chairman, Chief, chronic, Civile, clinical, closure, collaboration, collectively, commercialize, consist, contingent, criteria, daily, denominated, destroyed, efficiency, ensure, entrance, Executive, extraordinary, face, failure, FASB, Fasidotril, formal, genital, heart, hypertension, III, inhibitor, Jersey, Kendall, labeling, licensed, loan, lung, maximize, men, met, Mining, Minnesota, Officer, percentage, phase, President, promotional, Rebecca, Recherche, resiquimod, rounding, salary, scope, separately, significantly, steep, Taiwan, term, termination, vasopeptidase, Weekly, women
Removed:
Administration, Alecia, Alphapharm, Apotex, appealed, assert, assuming, Barr, Cheminor, Commission, DeCoudreaux, dismissed, disorder, division, dysphoric, exclusivity, favor, Food, Geneva, instituted, judgment, Novex, Pen, Pharma, PMDD, premenstrual, Pty, range, receive, rehearing, ruled, summary, Teva, trial, unenforceable, United, upheld, USA
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 1994 Lilly Stock Plan
- 10.2 1998 Lilly Stock Plan
- 10.3 Change In Control Severance Pay Plan
- 10.4 Chairman of the Board Letter
- 11 Statement Re: Computation of Earnings Per Share
- 12 Statement Re: Computation of Ratio of Earnings
- 99 Cautionary Statement Under Private Securities
LLY similar filings
External links